Respiratory Fluoroquinolone Use and Influenza
- 1 July 2011
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 32 (7), 706-709
- https://doi.org/10.1086/660859
Abstract
We show that respiratory fluoroquinolone use is extremely seasonal and that fluoroquinolone use is strongly associated with influenza. In our time series model, instantaneous influenza activity was a significant predictor of use (P< .0001). Also, we estimated that reducing influenza activity by 20% would reduce prescriptions by 8%.Keywords
This publication has 15 references indexed in Scilit:
- A province-level risk factor analysis of fluoroquinolone consumption patterns in Canada (2000-06)Journal of Antimicrobial Chemotherapy, 2010
- The Effect of Universal Influenza Immunization on Antibiotic Prescriptions: An Ecological StudyClinical Infectious Diseases, 2009
- Antibiotic Prescription Rates for Acute Respiratory Tract Infections in US Ambulatory SettingsJama-Journal Of The American Medical Association, 2009
- Excess drug prescriptions during influenza and RSV seasons in the Netherlands: Potential implications for extended influenza vaccinationVaccine, 2009
- Reducing antibiotic use in influenza: challenges and rewardsClinical Microbiology & Infection, 2008
- Declining Antibiotic Prescriptions for Upper Respiratory Infections, 1993–2004Academic Emergency Medicine, 2007
- Impact of Rapid Diagnosis on Management of Adults Hospitalized With InfluenzaArchives of Internal Medicine, 2007
- Antibiotic use in ambulatory care in Europe (ESAC data 1997–2002): trends, regional differences and seasonal fluctuationsPharmacoepidemiology and Drug Safety, 2006
- Fluoroquinolone prescribing in the United States: 1995 to 2002American Journal Of Medicine, 2005
- The Effect of Influenza on Hospitalizations, Outpatient Visits, and Courses of Antibiotics in ChildrenThe New England Journal of Medicine, 2000